Polyurethane grafts: A viable alternative for dialysis arteriovenous access?

Asian Cardiovascular and Thoracic Annals

Volumn 11, Issue 4, 2003, Pages 314-318

  Peng, Chan Wearn ^a   Tan, Seck Guan ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

POLYURETHAN;

ADULT; AGED; CANNULATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; FOREARM; GRAFT PATENCY; GRAFT REJECTION; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PROSTHESIS MATERIAL; RETROSPECTIVE STUDY; REVIEW; THROMBOSIS; VASCULAR ACCESS;

EID: 1242285575     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230301100409     Document Type: Review

References (16)

1. Kolff WJ, Berk HTJ, ter Welle M, van der Ley AJ, van Dijk EC, van Noordwijk J. The artificial kidney: a dialyser with a great area. Acta Med Scand 1944;117:121-34.
2. Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966;275:1089-92.
3. Girardet RE, Hackett RE, Goodwin NJ, Friedman EA. Thirteen months experience with the saphenous vein graft arteriovenous fistula for maintenance hemodialysis. Trans Am Soc Artif Intern Organs 1970;16:285-91.
4. Mindich B, Silverman M, Elguezabel A, Flores L, Sheka RP, Levowitz BS. Human umbilical cord vein for vascular replacement: preliminary report and observations. Surgery 1977;81:152-60.
5. Allen RD, Yuill E, Nankivell BJ, Francis DM. Australian multicentre evaluation of a new polyurethane vascular access graft. Aust N Z J Surg 1996;66:738-42.
6. Connolly JE, Brownell DA, Levine EF, McCart PM. Complications of renal dialysis access procedures. Arch Surg 1984;119:1325-8.
7. Kherlakian GM, Roedersheimer LR, Arbaugh JJ, Newmark KJ, King LR. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am J Surg 1986; 152:238-43.
8. Cinat ME, Hopkins J, Wilson SE. A prospective evaluation of PTFE graft patency and surveillance techniques in hemodialysis access. Ann Vasc Surg 1999;13:191-8.
9. Lawrence HS. Uremia - Nature's immunosuppressive device. Ann Intern Med 1965;62:166-70.
10. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986;315:91-6.
11. Nghiem DD, Schulak JA, Corry RJ. Management of the infected hemodialysis access grafts. Trans Am Soc Artif Intern Organs 1983;29:360-2.
12. Taylor B, Sigley RD, May KJ. Fate of infected and eroded hemodialysis grafts and autogenous fistulas. Am J Surg 1993;165:632-6.
13. Chia KH, Ong HS, Teoh MK, Lim TT, Tan SG. Chronic haemodialysis with PTFE arterio-venous grafts. Singapore Med J 1999;40:685-90.
14. Bartlett ST, Schweitzer EJ, Roberts JE, Jaekels JL, Sandager GL, Johnson LB, et al. Early experience with a new ePTFE vascular prosthesis for hemodialysis. Am J Surg 1995;170:118-22.
15. Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM, Tilney NL. Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 1985;202: 235-9.
16. National Kidney Foundation Dialysis Outcomes Quality Initiative. NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 1997;30(Suppl 3): 150-91.